Out-licensing

The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More

Our client company has developed an innovative frozen lozenge technology designed to deliver pharmaceuticals and OTC products, which offers a new alternative administration method for paediatric and otherwise difficult to swallow therapeutics. More

The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More

Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More

NexACT(R) utilizes highly effective, novel excipients or “penetration enhancers” to dramatically improve absorption and bioavailability of drugs. Varying the concentration of the enhancer allows for local or systemic delivery of drug, as desired. More

This newly developed dose measuring technology comprises of a thin foil that dissolves readily in the mouth thereby administering the exact dosage of certain medications. More

Innovative Endotracheal Tube for Prevention of Ventilator-Associated Pneumonia in Children More